Literature DB >> 2391449

Suppression of late phase enhanced vascular permeability in rats by selective depletion of neutrophils with a monoclonal antibody.

S Sekiya1, T Yamashita, F Sendo.   

Abstract

We investigated the role of neutrophils in increased vascular permeability by a selective reduction of neutrophils using a monoclonal antibody, RP-3. An intraperitoneal injection of RP-3 not only selectively depleted peripheral blood neutrophils, but prevented the neutrophil infiltration to the tissues. Proteose peptone, zymosan, and BCG induced three different types of inflammatory edema, showing the early phase only, early plus late phase, and the late phase only, respectively. Only the late phase response of zymosan and BCG was inhibited by a depletion of neutrophils by RP-3, though the early phase response induced by proteose peptone and zymosan was not affected. Reconstitution of neutrophil-depleted rats by in situ injection of these cells restored the inflammatory edema induced by BCG, depending upon the number of neutrophils injected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391449     DOI: 10.1002/jlb.48.3.258

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  4 in total

1.  Endothelial gaps and adherent leukocytes in allergen-induced early- and late-phase plasma leakage in rat airways.

Authors:  P Baluk; P Bolton; A Hirata; G Thurston; D M McDonald
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

2.  STIM1 and STIM2 cooperatively regulate mouse neutrophil store-operated calcium entry and cytokine production.

Authors:  Regina A Clemens; Joshua Chong; Derayvia Grimes; Yongmei Hu; Clifford A Lowell
Journal:  Blood       Date:  2017-07-19       Impact factor: 22.113

3.  Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.

Authors:  Sophie Gautier; Thavarak Ouk; Olivier Petrault; Jacques Caron; Régis Bordet
Journal:  Br J Pharmacol       Date:  2009-02-04       Impact factor: 8.739

Review 4.  Targeting of neutrophil activation in the early phase of the disease for prevention of Coronavirus disease-19 severity.

Authors:  Fujiro Sendo; Hiroshi Yoshitake; Yoshihiko Araki
Journal:  Microbiol Immunol       Date:  2022-04-20       Impact factor: 2.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.